PMID- 26985678 OWN - NLM STAT- MEDLINE DCOM- 20161229 LR - 20220318 IS - 1791-2431 (Electronic) IS - 1021-335X (Linking) VI - 35 IP - 5 DP - 2016 May TI - Strong inflammatory response and Th1-polarization profile in children with acute lymphoblastic leukemia without apparent infection. PG - 2699-706 LID - 10.3892/or.2016.4657 [doi] AB - Children with acute lymphoblastic leukemia (ALL) often present fever. Febrile states are usually associated with infectious processes that generate an inflammatory response involving various molecules, including cytokines. However, an inflammatory response may also occur in the absence of infection. We hypothesized that the levels of inflammatory cytokines are increased in children with ALL without apparent infection. The serum levels of 13 cytokines in 99 patients with ALL and 48 non-oncological patients without apparent infection were measured using multiplex analyte profiling technology (Luminex(R)). The concentration of circulating pro-inflammatory cytokines associated with fever was similar between patients with ALL and fever at diagnosis and those without fever. The levels of tumor necrosis factor alpha, interleukin (IL)-6, IL-8, monocyte chemoattractant protein-1 (MCP-1) and IL-10 were higher in patients with ALL vs. the control group (P<0.05). Moreover, the levels of the T helper 1 (interferon‑gamma and IL-12) cytokines were higher in patients with ALL vs. the control group. Transforming growth factor beta was lower in patients with ALL vs. the control group (P<0.05). The levels of IL-1beta, IL-2, IL-4, IL-13, and IL-17 were similar in the two groups. Our results indicate that the circulating levels of seven of the important studied cytokines are elevated in patients with newly diagnosed ALL without apparent infection, reflecting a strong and deregulated inflammatory state in this disease, with a Th1-polarization profile. FAU - Perez-Figueroa, E AU - Perez-Figueroa E AD - Immunology and Proteomics Research Laboratory, Children's Hospital of Mexico Federico Gomez, Mexico, D.F., Mexico. FAU - Sanchez-Cuaxospa, M AU - Sanchez-Cuaxospa M AD - Immunology and Proteomics Research Laboratory, Children's Hospital of Mexico Federico Gomez, Mexico, D.F., Mexico. FAU - Martinez-Soto, K A AU - Martinez-Soto KA AD - Immunology and Proteomics Research Laboratory, Children's Hospital of Mexico Federico Gomez, Mexico, D.F., Mexico. FAU - Sanchez-Zauco, N AU - Sanchez-Zauco N AD - Immunology and Proteomics Research Laboratory, Children's Hospital of Mexico Federico Gomez, Mexico, D.F., Mexico. FAU - Medina-Sanson, A AU - Medina-Sanson A AD - Department of Hematology-Oncology, Children's Hospital of Mexico Federico Gomez, Mexico, D.F., Mexico. FAU - Jimenez-Hernandez, E AU - Jimenez-Hernandez E AD - Oncology Service, Children's Hospital Moctezuma, Mexico, D.F., Mexico. FAU - Torres-Nava, J R AU - Torres-Nava JR AD - Oncology Service, Children's Hospital Moctezuma, Mexico, D.F., Mexico. FAU - Felix-Castro, J M AU - Felix-Castro JM AD - Oncology Service, Highly Specialized Unit, General Hospital National Medical Center La Raza, Mexican Institute of Social Security, Mexico, D.F., Mexico. FAU - Gomez, A AU - Gomez A AD - Research Unit on Infectious Diseases, Pediatric Hospital, National Medical Center XXI Century, Mexican Institute of Social Security, Mexico, D.F., Mexico. FAU - Ortega, E AU - Ortega E AD - Department of Immunology, Institute for Biomedical Research, National Autonomous University of Mexico, Mexico, D.F., Mexico. FAU - Maldonado-Bernal, C AU - Maldonado-Bernal C AD - Immunology and Proteomics Research Laboratory, Children's Hospital of Mexico Federico Gomez, Mexico, D.F., Mexico. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160307 PL - Greece TA - Oncol Rep JT - Oncology reports JID - 9422756 RN - 0 (Chemokines) SB - IM MH - Adolescent MH - Cell Polarity MH - Chemokines/blood MH - Child MH - Child, Preschool MH - Female MH - Fever/blood/immunology MH - Humans MH - Infant MH - Male MH - Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood/*immunology MH - Th1 Cells/*physiology EDAT- 2016/03/18 06:00 MHDA- 2016/12/31 06:00 CRDT- 2016/03/18 06:00 PHST- 2015/11/06 00:00 [received] PHST- 2015/12/17 00:00 [accepted] PHST- 2016/03/18 06:00 [entrez] PHST- 2016/03/18 06:00 [pubmed] PHST- 2016/12/31 06:00 [medline] AID - 10.3892/or.2016.4657 [doi] PST - ppublish SO - Oncol Rep. 2016 May;35(5):2699-706. doi: 10.3892/or.2016.4657. Epub 2016 Mar 7.